Sony to release PS4 this year for around $430 - media
TOKYO (Reuters) - Sony Corp (6758.T) plans to release its new PlayStation 4 home console this year for around $430, giving the successor to the popular PS3 a touch panel control and easy access to social networking sites such as Twitter and Facebook, Japan's Asahi newspaper reported.
Sony's game chief, Andrew House, will reveal the new features at a PlayStation meeting in New York on February 20, the paper said, without saying where it obtained the information.
Sony declined to comment on the report.
The gathering in New York is the first major PlayStation meeting in two years. The last time Sony held such an event it revealed the prototype for its handheld Vita. The meeting before that in 2005 came two months after it revealed its concept for the PS3, which sold 70 million units.
It has been more than six years since Sony launched the PS3, a longer gap than between the PS3 and its PS2 predecessor. The gaming market has since been transformed by the rise of tablet PCs and smartphones that are wooing away casual gamers with free or cheap games.
The shift to mobile devices has forced console makers such as Sony, Nintendo Co Ltd 7974.OS and Microsoft Corp (MSFT.O) to try to find new ways to win back consumers to consoles.
In a sign of the competitive pressure they face, Nintendo last month cut its sales target for the Wii U, successor to its 100 million-selling Wii, to 4 million machines by the end of March from its launch in November, compared with an earlier forecast for 5.5 million.
Shares in Sony, which is due to release its third-quarter results later in the day, last traded up 4.0 percent at 1,540 yen, in a broader market down nearly 1.0 percent.
(Reporting by Tim Kelly; Editing by Richard Pullin)
- Tweet this
- Share this
- Digg this
Half of India's thermal power stations have less than a week's supply of coal on hand, according to weekly data, the lowest level since mid-2012 when millions of people were left without power in one of the world's worst blackouts. Full Article
In race for bigger margins, drug makers willing to lose the India "advantage". Full Article